With the cytoactiv® test you may offer a major benefit to your senders: gynecologists are now in a position to inform their patients in a fast, clear and reliable way what the prognosis is for LSIL / HSIL.

The cytoactiv® test is designed to give patients more clarity whether the L1 capsid protein, which is necessary to stimulate the patient's self-healing powers, is present or not.

Demonstrate your diagnostic competence with our cytoactiv® test, which will provide the gynecologists and, of course, the patients with a fast and precise result.

Latest News

Latest multi-center study

published online in "Nature Modern Pathology".

For further information please go to "Press Releases"

Further information

Go to top